Department of Neurosurgery, University at Buffalo, State University of New York, Buffalo, New York, USA.
Neurosurgery. 2013 Feb;72(2):232-9. doi: 10.1227/NEU.0b013e31827b93ea.
Whether the addition of stenting to intracranial aneurysm coil embolization results in benefit in terms of occlusion rates or additional risk in terms of periprocedural adverse events is not clear.
To report retrospectively analyzed results of endovascular aneurysm treatment comparing stent-assisted coiling with coiling without stents at our hospital from 2005 to 2009.
In this retrospectively reviewed case series, aneurysms were grouped as intent-to-treat or initially treated with stent-assisted coiling (A) vs coiling alone (B) or as-treated-those that ultimately received a stent (C) or not (D). Complication and occlusion rates were compared between groups. Some patients crossed from group B to C after receiving stent placement at a later treatment following the initial therapeutic modality (without a stent).
In 459 patients, 489 aneurysms were treated by group as follows: A = 181, B = 308, C = 225, and D = 264. In stent groups (A and C), there were significantly lower frequencies of ruptured aneurysms (A vs B = 11% vs 62%, P < .001; C vs D = 20.4% vs 62.5%, P < .001) and more giant aneurysms (A vs B = 7.3% vs 1.0%, P = .001; C vs D = 5.9% vs 1.1%, P < .001). There was no statistically significant difference in permanent event-related morbidity (A vs B = 4.4% vs 4.2%, P = 1.0; C vs D = 4.4% vs 4.2%, P = 1.0). Average angiographic follow-up after last treatment was 18.2 ± 15 months (median = 14). Higher rates of complete occlusion at last angiographic follow-up were observed in stented aneurysms (A vs B = 64.6% vs 49.7%, P = .001; C vs D = 62.7% vs 48.9%, P = .003).
Stent-assisted aneurysm treatment resulted in higher total occlusion rates than non-stent-assisted treatment, with acceptable, comparable periprocedural event rates.
在颅内动脉瘤血管内弹簧圈栓塞术中添加支架是否能提高闭塞率,或者是否会增加围手术期不良事件的风险,目前尚不清楚。
本研究回顾性分析了 2005 年至 2009 年我院血管内治疗动脉瘤的结果,比较了支架辅助弹簧圈栓塞与单纯弹簧圈栓塞的效果。
在这项回顾性病例系列研究中,根据意向治疗或初始治疗方法将动脉瘤分为支架辅助弹簧圈栓塞组(A 组)与单纯弹簧圈栓塞组(B 组)、支架辅助弹簧圈栓塞组(A 组)与最终接受支架(C 组)或未接受支架(D 组)。比较各组之间的并发症和闭塞率。一些患者在初始治疗方式(无支架)后,接受了后续的支架置入治疗,从 B 组转变为 C 组。
在 459 例患者的 489 个动脉瘤中,根据治疗方法分为以下几组:A 组 181 例,B 组 308 例,C 组 225 例,D 组 264 例。在支架组(A 组和 C 组)中,破裂动脉瘤的发生率明显较低(A 组与 B 组比较为 11%比 62%,P<0.001;C 组与 D 组比较为 20.4%比 62.5%,P<0.001),且巨大动脉瘤的比例也较高(A 组与 B 组比较为 7.3%比 1.0%,P=0.001;C 组与 D 组比较为 5.9%比 1.1%,P<0.001)。永久性与事件相关的发病率无统计学差异(A 组与 B 组比较为 4.4%比 4.2%,P=1.0;C 组与 D 组比较为 4.4%比 4.2%,P=1.0)。末次治疗后平均血管造影随访时间为 18.2±15 个月(中位数=14 个月)。支架辅助治疗的动脉瘤在末次血管造影随访时完全闭塞率较高(A 组与 B 组比较为 64.6%比 49.7%,P=0.001;C 组与 D 组比较为 62.7%比 48.9%,P=0.003)。
支架辅助动脉瘤治疗的总闭塞率高于非支架辅助治疗,且围手术期不良事件发生率可接受且相似。